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ABSTRACT 
 
Epidemiological and clinical studies indicate a close relationship between obesity and asthma. 
Here, we determined the impact of diet-induced obesity on the expression levels of IL-1β, IRAK-
1 and TRAF-6 mRNA as well as IL-1β protein level and pathological changes in male Wistar rat’s 
lung after sensitization with ovalbumin (OVA).  
Twenty male Wistar rats divided into four groups, control with normal diet (C+ND), OVA-
sensitized with normal diet (S+ND), control with high-fat diet (C+HFD), and OVA-sensitized 
with high-fat diet (S+HFD). All rats fed for 12 weeks with standard pellets or high-fat diet while 
sensitization and challenging with OVA or saline were done for groups in the last month. In the 
end of intervention, lung was isolated and tested for the expression levels of IL-1β, IRAK-1 and 
TRAF-6 mRNA with real time-PCR method, and pathological changes were determined.  
Diet-induced obesity groups showed increased weight, obesity indexes and lipid profiles The 
expression levels of IL-1β mRNA in OVA-sensitization groups (S+ND and S+HFD) showed a 
significant increase compared with other groups. Also in S+HFD group, expression level of 
IRAK-1 and TRAF-6 mRNA were markedly higher than other groups (p<0.001). The 
pathological changes were marked in sensitized groups compared to non-sensitized groups; with 
marked increase in obese sensitized rat.  
The results showed that high fat diet caused overexpression of IL-1β, IRAK-1 and TRAF-6 
mRNA as well as IL-1β protein in an experimental model of asthma. Our results suggest that 
obese-asthmatic conditions may lead to the local production and activation of pro-inflammatory 
agents. 
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INTRODUCTION 
 
Obesity is an excess abdominal body fat state
1
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which is considered as a risk factor for asthma.
2
 In the 
human studies it has become apparent that most people 
with asthma are overweight or obese subjects.
3
 
Accordingly, clinical reports have shown that obesity 
caused increased prevalence of asthma
4
 and worse the 
clinical outcomes.
5
 In addition, weight loss in obese 
people with asthma caused a decrease in intensity of 
asthma symptoms.
6,7
 Different mechanisms describe 
how obesity impact on asthma,
8
 nevertheless, the exact 
mechanism of asthma-obesity relationship remains 
uncertain. Obesity is associated with a chronic low-
grade systemic inflammation, characterized by 
presence of circulating leukocytes, production of 
abnormal cytokines/chemokines and activation of 
inflammatory signaling pathways.
9-11
 The effects of 
obesity on lung tissue involve in the inflammatory 
changes in pulmonary microenvironment.
12
 Therefore, 
it is important to understand the lung inflammation 
differences between obese and lean subjects. 
Inflammatory mediators and adipokines produced 
by adipose tissue exert their biological function in an 
autocrine, paracrine and systemic manner.
2
 It is thought 
that these mediators and adipokines contribute to the 
immune response in lung. A variety of inflammatory 
moieties are increased in the obese people.
13
 IL 
(interleukin)-1β is a key cytokine involved in systemic 
and local immune responses in obesity and asthma. IL-
1β is primarily produced by monocytes and 
macrophages, but other cells including epithelial, 
endothelial, B and T lymphocytes, have also been 
shown to release IL-1β.14,15 Externally injection of IL-
1β to isolated guinea pig airways has disrupted the 
isoproterenol-induced relaxation response.
16
 Also, 
treatment of animals with IL-1 receptor antagonist (IL-
1ra) could decrease hyper-responsiveness to 
histamine
17
 and substance P, and reduce lung 
inflammation and prevent leukocyte infiltration.
18
 
Several evidences are available indicating the 
synthesis and non-regulated release of IL-1β in chronic 
inflammatory conditions such as inflammatory bowel 
diseases, psoriasis and rheumatoid arthritis.
18
 On the 
other hand, the impact of IL-1β on contraction and 
relaxation responses in asthmatic patient through the 
direct effect on airways has been shown.
19
 Taken 
together, IL-1β has key role in the pathophysiology of 
asthma. In signaling pathway, IL-1β forms a ligand-
induced complex with IL-1 type I receptor (IL-1RI) and 
IL-1 receptor accessory protein (IL-1RAcP). Then, IL-
1 receptor associated kinase (IRAK)-1 attaches to 
receptor complex. Finally, following the activation of 
IRAK-1, it interacts with tumor necrosis factor receptor 
associated factor (TRAF)-6 which is required for the 
activation of IL-1-induced NF-Κb.20 This study was 
designed to determine the expression levels of IL-1β, 
IRAK-1 and TRAF-6 mRNA as well as IL-1β protein 
in the lung tissue and evaluate the differences between 
the  mRNA expressions in obese and lean male Wistar 
rats in experimental asthmatic model. 
 
MATERIALS AND METHODS 
 
Animals and Diets 
Twenty male Wistar rats (8 weeks old, weighing 
approximately 160 g) were obtained from animal house 
of Tabriz University of Medical Science. All animals 
were placed in cages under controlled conditions at 22

 
C with a 12-12h light-dark cycle and 50-60% humidity. 
Food and water throughout the accommodation and 
experimental period was provided ad libitum. 
After a week of accommodation, all rats randomly 
divided to four groups (5 rats in each group), including: 
control with normal diet (C+ND), OVA-sensitized with 
normal diet (S+ND), control with high-fat diet 
(C+HFD), and OVA-sensitized with high-fat diet 
(S+HFD). Diet-induced obesity (DIO) model was 
prepared according to the method of previous study.
21,22
 
Briefly, in DIO groups (C+HFD and S+HFD), rats 
were fed with high fat diets (42 % energy from fat, 
19% energy from protein and 39% energy from 
carbohydrate) and other rats (C+ND and S+ND) were 
fed standard rat chow (11% energy from fat, 28% 
energy from protein and 61% energy from 
carbohydrate). 
After 8 weeks, sensitization of animals to 
ovalbumin (OVA) in S+ND and S+HFD groups was 
performed with the following protocol. The experiment 
continued for four weeks by OVA sensitization along 
with the previous regime.  
 
Animal Sensitization  
Sensitization of animals to OVA in S+ND and 
S+HFD groups was performed using the method 
described previously.
23,24
 Briefly, 1 mg OVA and 200 
mg Al (OH)3 (Sigma) per 1 ml of saline solution were 
injected intra-peritoneal (i.p) on day 1 and 8. From day 
14, the animals were placed in a closed chamber, with  
dimensions 30×20×20 cm, for exposing to an aerosol of 
4% OVA (solution in 2 ml of saline) for 18 ± 1 days 
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during 15 min daily using a nebulizer (CX3, Omron 
Health care Europe B.V., and the Netherlands). All 
control animals (C+ND and C+HFD) were treated 
similarly but saline was used instead of OVA solution. 
The study was approved by the ethical committee of 
Tabriz University of Medical Sciences (Acceptance 
number: 92/4-6/9).  
 
Body Weight 
The animals were weighted weekly on a certain day 
(at 16.00) during the experiment. At the end of study, 
rats were anesthetized by 50 mg/kg ketamine and 
xylazine (i.p). Then they were weighted and naso-anal 
length; the distance between nose and anus of rats; 
measured. Final body weight, Lee index, and 
percentage of body fat (BF %) were also determined 
for calculation of obesity indexes used in rodents. All 
obesity indexes described previously (reference for 
each index shown in Table 1). Briefly, Table 1 shows 
how all obesity indexes were calculated. 
 
Biochemical Measurements 
The fasted rats then anesthetized with ketamine and 
xylazine, blood samples (3-5 ml per rat) were collected 
from the heart into tubes without EDTA. The plasma 
total cholesterol (TC), triglycerides (TG) and HDL-C 
concentrations were measured using an auto blood 
analyzer (Bayer corp. USA). Triglyceride, total 
cholesterol and HDL-C kits were obtained from pars 
azmoon Co., Iran. LDL-C was evaluated using the 
friedewald formula: LDL-C= TC-[HDL-C+TG/5].
25
 
 
Lung Histopathological Evaluation 
Rats were anesthetized by ketamine and xylazine 
(i.p) and sacrificed. Their lungs and trachea were 
isolated and placed into 10% buffered formalin (37%, 
Merck, Germany). After seven days, the tissues were 
dried by passage through 70% to 100% ethanol. Then 
the tissues were cleared by xylene and embedded in 
paraffin. Finally the specimens were cut into 4-μm 
sections using an autotechnicon apparatus and stained 
with hematoxylin and eosin (H&E stain). The tissues 
were then evaluated under a light microscope. The 
pathologic changes in the lung of all groups including 
the lipid aggregation, the emphysema, lymphoid 
hypertrophy, airway smooth muscle hyperplasia and 
edematous changes were recorded. The pathological 
changes were scored according to the following grades: 
no pathologic changes=0; patchy changes=1; local 
changes=2; scattered changes=3 and severe changes (in 
the most parts of the lungs)=4. 
 
Lysate Preparation from Lung Tissue 
After anesthetized, the chest and the neck of the rats 
were opened and the lung was isolated for weighing 
and removing an appropriate amount of tissue. Tissue 
was grinded and homogenized for subsequent RNA 
extraction. After adding 600 μL of RNase-free water 
and 20 μL reconstituted proteinase K, lysate was 
incubated and spun for 1 min. To extract the RNA, 
about 650 μL of mixtures of lysate and ethanol was 
loaded to total RNA extraction column and centrifuged 
for 1 minute. Then, DNase I treatment performed 
followed by washing step. RNA was eluted from 
column and the purified RNA sample kept at −70°C for 
real time-PCR analysis.  
 
Real-Time PCR 
RNA content and purity were measured using 
Nanodrop 1000 spectrophotometer (Thermo scientific, 
Wilmington, DE, USA). For determination of IL-1β, 
IRAK-1 and TRAF-6 mRNA expression levels 
RevertAid First-Strand cDNA Synthesis Kit 
(Fermentas GmBH, Leon-Rot, Germany) with the aid 
of random hexamer primers and MMLV reverse 
transcriptase (as a complete system for efficient 
synthesis of first-strand cDNA from mRNA or total 
RNA templates) were used. 
Each cDNA was used as a template for separate 
assay for mRNA quantitative real-time PCR by using 
SYBR Green master mix. 
 
Table 1. Obesity indexes formula 
Obesity index Formula Reference 
Percentage of body weight changes (%) [(Final weight-initial weight)/initial weight] ×100 (22) 
Lee index (mg/mm) Final weight0.33/naso-anal length (50) 
Percentage of body fat (%) 0.73(lee index-280.8) (50) 
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Table 2. Primer set list for analyzing the gene expressions 
Gene name Accession number Primer sequencea 
IL-1β NM_031512 Forward Primer   5'- AGA GTG TGG ATC CCA AAC AA -3' 
Reverse Primer   5'- AGT CAA CTA TGT CCC GAC CA -3' 
TRAF-6 NM_001107754.2 Forward Primer  5'-CAG TCC CCT GCA CATT-3' 
Reverse Primer   3'-GAG GAG GCA TCG CAT-5' 
IRAK-1 NM_001127555 Forward Primer   5'- GAG AGT GTT CCT GGC CTC TC -3' 
Reverse Primer   5'- GCT GGG TTG ATG ATG ATC TG -3' 
Beta Gusp NM_017015 Forward Primer   5'-GTGGGGATAATGACTTGCAG -3' 
Reverse Primer   5'- GGAACCCCTGGTAGAACAGT-3' 
a. Sequences were derived from NCBI (www.ncbi.nlm.nih.gov) 
 
Table 2 shows locked nucleic acid (LNA) forward 
and reverse primer sets (Exiqon) for analyzing the gene 
expressions. Real-time PCR reactions were performed 
on a Rotor-Gene 6000 instrument (Corbett Life 
Science, Australia). 
The amount of PCR products of mRNA extracted 
samples was normalized to the PCR products of 
housekeeping beta-glucuronidase gene.
26
 The 2
-(ΔΔ Ct)
 
method was used to determine relative quantitative 
levels of IL-1β, IRAK-1 and TRAF-6 mRNA. The 
results were expressed as fold change versus the 
relevant controls.
27
 
 
Tissue Sampling and Protein Measurement  
At the end of study period, rats were anesthetized 
with an i.p injection of ketamine (50 mg/kg) and 
xylasin (5 mg/kg) and sacrificed. Then lung tissues 
were removed and after quick freezing in liquid 
nitrogen, all tissues transferred to -70 °C temperature 
until IL-1β measurement.  
Tissue samples were weighted, homogenized in 
PBS (pH 7.2-7.4) and centrifuged for 20 min at the 
speed of 3000 rpm and 4°C. Then supernatants were 
removed and IL-1β protein was measured using 
sandwich rat ELISA kits according to the 
manufacturer’s instructions (Boster Biological 
Technology Co., Ltd, catalog: CA, 94566). 
 
Statistical Analysis 
Results are given as the mean ±SD. The data 
between different groups were compared using one 
way analysis of variance (ANOVA) with Tukey-
Kramer post hoc-test. p less than 0.05 was considered 
significant. The correlation between IL-1β, IRAK-1 
and TRAF-6 mRNA levels with weight were calculated 
by pearson’s correlation coefficient. 
 
RESULTS 
 
Body Weight 
Table 3 showed the mean (±SD) of initial body 
weight, final body weight, Lee index, and percentage of 
body fat for all groups. In the present study, results 
showed that diet-induced obesity caused significant 
increase in final body weight, Lee index, and 
percentage of body fat in C+HFD and S+HFD animals 
compared to C+ND and S+ND animals (p<0.05 to 
 
Table 3. Weight changes and obesity indexes in experimental groups 
variables C+ND S+ND C+HFD S+HFD 
Initial body weight (gr) 159±5.43 152.80±8.25 154.80±4.81 156±7.96 
Final body weight (gr) 317.20±25.05 318.00±24.89 355.40±10.13 371±28.12* 
+ 
Percentage of body weight change (%) 99.28±9.75 108.48±11.70 129.78±10.13** 
+ 
137.83±13.92*** 
++ 
Lee index (mg/mm) 305.29±6.83 307.58±6.16 320.04±2.53** 
++ 
321.15±2.87** 
++ 
Percentage of body fat (%) 17.87±4.98 19.54±4.5 28.64±1.85** 
++ 
29.45±2.09** 
++ 
Values are represent as mean±SD. C+ND; control with normal diet, S+ND; OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; 
OVA-sensitized with high-fat diet. Differences between the results of C+ND with those of other groups; * p<0.05, ** p<0.01, *** p<0.001. Differences 
between the results of S+ND with those of control high fat diet and sensitized high fat diet; + p<0.05, ++ p<0.01, +++ p<0.001. For each group, n=5. 
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Figure 1. The serum levels of total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C) and low density 
lipoprotein (LDL-C) in experimental groups. Values are depicted as mean±SD. C+ND; control with normal diet, S+ND; 
OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; OVA-sensitized with high-fat diet. Statistical 
differences between the control and other groups; *; p<0.05, **; p<0.01, ***; p<0.001.Statistical differences between the 
sensitized normal diet with obese groups; +; p<0.05, ++; p<0.01, +++; p<0.001. For each group, n=5. 
 
 
p<0.001). However, there were no significant 
differences in weight changes between lean (C+ND vs 
S+ND) and obese groups (C+HFD vs S+HFD). 
 
Serum Lipid Profile 
Figure 1 presented the lipid profile (TC, TG, HDL-
C and LDL-C) in all groups. Lipid profile in obese 
groups (C+HFD and S+HFD) were significantly higher 
than the control groups (p<0.05 to p<0.001). With the 
exception of differences in HDL between C+ND and 
S+ND (p<0.05), the significant differences between the 
control groups (C+ND versus S+ND) and obese groups 
(C+HFD versus S+HFD) were not observed. 
 
Lung Histopathology 
With regard to our scoring described in materials 
and methods section, OVA-sensitization caused a 
significant elevation in lymphoid hypertrophy, airway 
smooth muscle hyperplasia and emphysema 
pathological changes in sensitized groups (S+ND and 
S+HFD) compared to non-sensitized groups (C+ND 
and C+HFD), (p<0.05 to p<0.001, Figure 2 and 3b to 
d). Also, after diet-induced obesity, lipid aggregation in 
lung tissue significantly enhanced in obese groups 
(C+HFD and S+HFD) in comparison with normal diet 
groups (C+ND and S+ND), (p<0.05 to p<0.001, Figure 
2 and 3a). The edematous pathological changes in 
C+HFD, S+ND and S+HFD were significantly higher 
than those in C+ND group (p<0.001 for all cases, 
Figure 2 and 3e), but there were no significant 
differences between other groups. On the other hand, 
the airway smooth muscle pathological changes in 
S+HFD significantly were increased compared to 
S+ND group (p<0.001, Figure 2 and 3c), and the 
emphysema pathological change in S+HFD was non-
significant higher than S+ND (p=0.093, Figure 2 and 
3d). Although the lymphoid hypertrophy pathological 
change was higher in S+HFD group than S+ND group, 
but this difference was not statistically significant.  
 
IL-1β mRNA Expression in Lung Tissue 
As seen in Figure 4, there was a significant increase 
in rat lung of IL-1β mRNA expression of S+HFD 
group compared with other groups (p<0.05 to 
p<0.001). The level of rat lung IL-1β mRNA 
expression in S+ND group was also significantly 
higher than C+ND (p<0.05). There was no significant 
difference between C+ND and C+HFD groups. 
 
Relationship between IL-1β mRNA Expression and 
Obesity Indexes 
A significant positive correlation was found  
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Figure 2. Photographs of a lung specimen in different groups (magnification for each group; 10 × 20). Control with normal 
diet (C+ND), OVA-sensitized with normal diet (S+ND), control with high-fat diet (C+HFD), and OVA-sensitized with high-
fat diet (S+HFD).  
 
 
between IL-1β mRNA expression and percentage of 
weight changes (r=0.547, p<0.05; Figure 5). This 
correlation was not significant in other obesity indexes, 
Lee index (r=0.259, p=0.271) and percentage of 
bodyfat (r=0.259, p=0.271). 
 
IRAK-1 mRNA Expression in Lung Tissue 
In Figure 6, IRAK-1 mRNA expressions in lung 
tissue of different groups are shown. The IRAK-1 
mRNA expressions in group S+HFD increased 
significantly compared to other groups (p<0.01 to 
p<0.001). There was not any significant difference 
among other groups.  
 
Relationship between IRAK-1 mRNA Expression 
and Obesity Indexes 
There was significant positive correlation between 
IRAK-1 mRNA expression with obesity indexes, 
percentage of weight changes (r=0.658, p=0.002), Lee 
index (r=0.578, p=0.008) and percentage of body fat 
(r=0.578, p=0.008; Figure 7).  
 
TRAF-6 mRNA Expression in Lung Tissue 
Figure 8 shows that TRAF-6 mRNA expressions in 
group S+HFD increased significantly compared to 
C+ND, C+HFD, and S+ND groups (p<0.001). There 
was not any significant difference among other groups.  
 
Relationship between TRAF-6 mRNA Expression 
and Obesity Indexes 
Significant positive correlations between TRAF-6 
mRNA expression level and percentage of weight 
changes were observed in lung tissue (r=0.455, 
p=0.044; Figure 9). But these correlations were not 
significant when compared with Lee index (r=0.412, 
p=0.071) and percentage of body fat (r=0.412, p=0.71).  
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Figure 3. The lipid aggregation (a), lymphoid hypertrophy (b), airway smooth muscle hyperplasia (c), emphysema (d), and 
edematous changes (e) of lungs in control with normal diet (C+ND), OVA-sensitized with normal diet (S+ND), control with 
high-fat diet (C+HFD), and OVA-sensitized with high-fat diet (S+HFD), (for each group, n=5). Differences between the 
results of C+ND with those of other groups; **; p<0.01, ***; p<0.001. Differences between the results of S+ND with those of 
control high fat diet and sensitized high fat diet; +; p<0.05, ++; p<0.01, +++; p<0.001. Difference between the results of 
C+HFD with S+HFD; ###; p<0.001. 
 
IL-1β Protein Levels in Lung Tissue 
The data presented in Figure 10, demonstrates that 
OVA-sensitization and challenging caused significant 
increase in IL-1β protein levels in sensitized groups 
(S+ND and S+HFD) compared with non-sensitized 
groups (C+ND and C+HFD), (p<0.05 to p<0.001). 
Also, diet-induced obesity, resulted in a significant 
increase in the level of IL-1β protein in S+HFD group 
when compared with S+ND group (p<0.01). There was 
not significant difference between C+ND and C+HFD 
group. 
 
 
 
M.R. Aslani, et al. 
190/ Iran J Allergy Asthma Immunol, Summer 2016                            Vol. 15, No. 3, June 2016 
Published by Tehran University of Medical Sciences (http://ijaai.tums.ac.ir) 
 
IL
-1

m
R
N
A



g
lu
c
u
ro
n
id
a
s
e
(F
o
ld
 c
h
a
n
g
e
)
0
1
2
3
4
*
***
C+ND S+ND C+HFD S+HFD
+
###
 
Figure 4. Expression level of IL-1β mRNA in the lung tissue of experimental groups.Values are depicted as mean±SD. C+ND; 
control with normal diet, S+ND; OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; OVA-
sensitized with high-fat diet. Statistical differences between the C+ND and other groups;***; p<0.001. Statistical differences 
between the S+ND vs obese groups;+; p<0.05. Statistical difference between C+HFD vs S+HFD; ###; p<0.001. For each 
group, n=5. 
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Figure 5. Pearson correlation analysis of IL-1β mRNA with percentage of body weight changes in the study groups. There 
was a significant positive correlation between IL-1 mRNA expression and percentage of body weight changes (correlation 
coefficient=0.547, p<0.05). 
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Figure 6. Expression level of IRAK-1 mRNA in the lung tissue of experimental groups.Values are depicted as mean±SD. 
C+ND; control with normal diet, S+ND; OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; OVA-
sensitized with high-fat diet, TRAF-6; TNF receptor associated factor-6. Differences between the results of normal diet with 
those of other groups; ***; p<0.001. Differences between the results of S+ND with those of high fat diet groups; +++; p<0.001. 
Difference between the results of C+HFD with S+HFD; ##; p<0.01. For each group, n=5. 
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Figure 7. Pearson correlation analysis of IRAK-1 mRNA with percentage of body weight changes in the study groups. There 
was a significant positive correlation between IRAK-1 mRNA expression and percentage of body weight changes (correlation 
coefficient=0.658, p<0.01). 
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Figure 8. Expression level of TRAF-6 mRNA in the lung tissue of experimental groups.Values are depicted as mean±SD. 
C+ND; control with normal diet, S+ND; OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; OVA-
sensitized with high-fat diet, TRAF-6; TNF receptor associated factor-6. Differences between the results of C+ND with those 
of other groups; ***; p<0.001.Differences between the results of S+ND with those of control high fat diet and sensitized high 
fat diet; +++; p<0.001. Difference between the results of C+HFD with S+HFD; ###; p<0.001. For each group, n=5. 
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Figure 9. Pearson correlation analysis of TRAF-6 mRNA with percentage of body weight changes in the study groups. There 
was a significant positive correlation between IL-1 mRNA expression and percentage of body weight changes (correlation 
coefficient=0.455, p<0.05). 
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Figure 10. Protein levels of IL-1β in the lung tissue of experimental groups.Values are depicted as mean±SD. C+ND; control 
with normal diet, S+ND; OVA-sensitized with normal diet, C+HFD; control with high-fat diet, S+HFD; OVA-sensitized with 
high-fat diet. Differences between the results of C+ND and those of other groups; **; p<0.01, ***; p<0.001. Differences 
between the results of S+ND and those of control high fat diet and sensitized high fat diet; +; p<0.05, ++; p<0.01. Difference 
between the results of C+HFD and S+HFD; ###; p<0.001. For each group, n=5.  
 
 
DISCUSSION 
 
It is well known that obesity is a low-grade chronic 
pro-inflammatory condition.
28
 It is unknown that how 
these conditions can lead to the development of airway 
inflammation and asthma in humans. Most 
experimental studies which have focused on the 
relationship between obesity, airway inflammation, and 
asthma, mainly used genetically engineered animals to 
show the possible mechanisms between obesity and 
asthma. But these genetically obese mice, such as leptin 
deficiency (ob/ob mouse) and leptin receptor deficiency 
mice (db/db mouse), have some complications 
including comorbid conditions affectingthe immune 
responses in airways.
29
 In this study we used the high 
fat diet to induce obesity in Wistar rats. Our results 
showed that diet-induced obesity caused increase in 
body weight and obesity indexes in rodent (percentage 
of weight changes, Lee index and fat percent) which 
was the in accordance with the previous studies.
21
 On 
the other hand, as a result of diet-induced obesity, lipid 
profile (total cholesterol, triglyceride, HDL-C and 
LDL-C) increased significantly in obese groups. 
Airway hyperresponsiveness (AHR), BAL fluid 
eosinophilia and smooth muscle hypertrophy are some 
characterize of human asthma. Airway remodeling is a 
pathophysiological characteristic of asthma, which is 
identified by goblet cell hyperplasia, increasing in 
thickness of basement membrane, sub-epithelial 
fibrosis, collagen deposition, angiogenesis and airway 
smooth muscle hypertrophy and hyperplasia.
30
 In our 
present study, OVA-sensitization showed some aspects 
of human asthma include lymphoid hypertrophy, 
airways smooth muscle hyperplasia, edema, and 
emphysema in lean and obese groups; with marked 
augmentation in obese sensitized rat. Previous studies 
have shown that some of histological changes in the 
lungs in obesity associate with asthma. Camergo and 
colleagues indicated that obesity caused decrease in 
airway caliber and increase in bronchial hyper 
reactivity in obese rats.
31
  
Obesity is a risk factor for asthma and causes an 
increase in the prevalence of asthma.
32
 Human and 
animal studies supported the relationship between 
obesity and asthma.
33-35
 In obese human and mice, 
chronic systemic inflammation characterized by 
elevation of circulating leukocytes and serum 
concentrations of cytokines, chemokine and acute 
phase proteins.
36,37
 Studies have shown that systemic 
inflammatory markers are associated with diseases 
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associated with obesity, such as type II diabetics and 
arthrosclerosis.
38,39
 These findings suggest that the 
inflammation functionally is very important in the 
development of these diseases. A variety of 
inflammatory moieties which are increased in obese 
individual blood, IL-1β and TNF-α are of particular 
interest.
40
 Specific cytokines, particularly IL-1β, have 
been shown to have a special role in altering the airway 
responsiveness in asthma.
41
 Hakonarson and his 
colleagues have revealed that airway smooth muscle 
could synthesize and release IL-1β in asthmatic patients 
and this indicated that IL-1β acts in an autocrine 
manner in airway smooth muscles.
16
 
Our results in the current study showed that 
sensitization with OVA caused to increase the 
expression level of IL-1β in male Wistar lung, which 
was in consistent with the previous findings.
42
 Also, in 
our study design, diet-induced obesity led to 
overexpression of IL-1β in lung compared to other 
groups. Another study has also shown such increase in 
IL-1β in lung tissue.43 Additionally, in current study, 
we showed that post translational changes in obese 
asthmatic condition resulted in production of IL-1β in 
the lung. 
Overexpression and enhanced production of IL-1β 
in obese and sensitized rat’s lung indicated the 
functional modification of lung tissue and led to 
autologous expression of IL-1β. On the other hand, 
studies reported that increase in the synthesis and 
release of IL-1β, result in the synthesis of other 
inflammatory mediators that may affect lung function 
leading to exacerbation of lung inflammation in 
asthma.
18
 Up regulation of IL-1β in lung in this study 
showed the autocrine mechanisms may involve in 
pathophysiology in obesity-asthmatic model. There are 
more evidences indicating the potential role of IL-1β in 
triggering the expression and release of a variety of 
interleukins, such as IL-1, IL-6, IL-8, IL-11 and IL-15, 
which can exacerbate the asthma condition in turn.
44
 
Also, it has been shown that the stimulatory effect of β-
arrestin on IL-17 in a murine asthma.
45
 Furthermore, 
the link between obesity with asthma, a number of 
hypotheses has been proposed which can be pointed to 
the role of obesity on immune responses. Adipose 
tissue in addition to the production of adipokines, such 
as leptin, is an important source of cytokines, such as 
IL-1β and TNF-α.46 These cytokines have an effect on 
the various processes in asthma, such as release of and 
IL-9, damag bronchial epithelial cells, recruitment and 
adhesion of eosinophil to airway epithelial cells, and 
bronchoconstriction.
46
 On the other hand, our results of 
histological examinations showed that fat tissue mass 
increased in the lungs after diet-induced obesity. It is 
inferred that the increase in fat mass in the lungs, as 
well as in visceral adipose tissue, can lead to an 
increase of adipokines in circulation and in the lungs 
tissue. Enhanced adipokines in lungs may change the 
airway responsiveness in obese asthmatic statue. The 
findings of the current study, such as histological 
changes and up regulation of IL-1β in obese asthmatic 
condition support the hypothesis that not only systemic 
but also local inflammation may be involved in 
pathophysiologic changes in obesity associated asthma 
statue.  
IL-1β exerts its signal transduction pathways 
through interaction with IRAK-1 after band with its 
receptors. Then IRAK-1 interacts with TRAF adaptor 
proteins, especially TRAF-6, which leading to 
activation of kind of transcription factors, such as NF-
κB and active protein (AP)-1.47 In the current study, the 
IRAK-1 and TRAF-6 expressions levels were 
examined in lung to better understanding of IL-1β roles 
in relationship between obesity and asthma. Diet-
induced obesity caused markedly overexpression of 
IRAK-1 and TRAF-6 mRNA in obese sensitized group. 
This elevated expression, at least in part, might explain 
the possible role of IL-1β in this condition and 
activation of its signal transduction pathways. It is 
noteworthy that other factors, such as Toll-like 
receptors and free fatty acids, are able to activate this 
signaling pathway and the authors cannot rule out the 
role of these factors in the activation of IL-1β signaling 
pathway, it needs further studies.
20
  
It should be noted that the complexity of the 
mechanisms responsible for exert IL-1β autocrine 
effects is difficult to explain in obesity with asthma. In 
fact, other members of IL-1 axis should be considered 
for better understanding of the role of IL-1β. Studies 
have shown that IL-1 exerts its effects through the IL-1 
type I receptor (IL-1RI), but type II receptors; both IL-
1RII and solution form of it (sIL-1RII) and solution 
form of IL-1RI (sIL-1RI), act as decoy receptors that 
are involved as damping effect for IL-1.
48
 Also, IL-1ra, 
an endogen IL-1 antagonist, should be considered in 
this axis. Based on available evidence, it seems that 
under normal conditions, IL-1β and other family 
members of IL-1 are involved to prevent excessive 
immune response in all cell type. On the other hand, in 
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certain disease conditions, there is an imbalance in the 
production of the IL-1β and other molecules in IL-1 
axis, this phenomenon might occur in obese with 
asthma. Although the expression of IL-1β mRNA 
increased in the current study, the role of other 
molecules involved in IL-1 axis cannot be ruled out. 
Perhaps the expression or activation of other molecules 
reduced or activated in obesity associated with asthma 
which further studies.
42
 So, the ratio of active (IL-1RI) 
to inactive (sIL-1RI, IL-1RII, and sIL-1RII) receptors 
may determine the amount of inflammation.  
We also examined the correlation between the 
expression of IL-1β, IRAK-1 and TRAF-6 mRNA with 
obesity indexes in rodent. Our result indicated that 
there was a weak positive correlation between the 
expression of IL-1β and TRAF-6 mRNA with 
percentage of weight changes in study groups. 
However, there was not any significant correlation 
between IL-1β and TRAF-6 mRNA with Lee index and 
percentage of body fat. This study showed that in 
asthmatic condition, increase in weight changes 
enhances expression of pro-inflammatory cytokine, IL-
1β. Studies have shown that asthma is a chronic 
inflammatory state which increases conventional 
biomarkers, such as eosinophil and eNO. But, in the 
obesity associated with asthma, studies reported that 
these biomarkers do not increase substantially with 
increasing body mass index (BMI). The authors 
suggested that other mechanisms may involve in its 
pathophysiology in the obesity associated with 
asthma.
49
 Based on the above observation, it is 
conceivable that asthma phenotype might change in 
obesity condition. In conclusion, our results showed 
that in the lung of male OVA-sensitized rats, diet-
induced obesity lead to an increased expression of IL-
1β, IRAK-1 and TRAF-6 mRNA. IL-1β is a key 
cytokine which has pro-inflammatory effects in all cell 
types. Many animal and human studies indicated that 
different kinds of cytokines increase in obesity with 
asthma condition. Up regulation of IL-1β in obesity 
state may result in exacerbation of inflammation of 
airways in asthma. Enhanced circulating IL-1β with its 
autocrine effect may involve in synergistically increase 
of inflammation in obesity associated with asthma in 
airways. Furthermore, signaling pathway molecules of 
IL-1β are IRAK-1 and TRAF-6. Increased expressions 
of IRAK-1 and TRAF-6 mRNA in this study, at least in 
part, can show activation of IL-1β signaling pathways.  
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